Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Nevro Corp    NVRO

NEVRO CORP (NVRO)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/10/2018 01/11/2018 01/12/2018 01/16/2018 01/17/2018 Date
78.64(c) 78.09(c) 78.56(c) 79.75(c) 77.89(c) Last
655 629 338 235 402 762 679 030 370 232 Volume
+0.99% -0.70% +0.60% +1.51% -2.33% Change
More quotes
Financials ($)
Sales 2017 320 M
EBIT 2017 -26,0 M
Net income 2017 -34,3 M
Finance 2017 13,6 M
Yield 2017 -
Sales 2018 404 M
EBIT 2018 2,76 M
Net income 2018 -8,68 M
Finance 2018 64,3 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 7,35x
EV / Sales2018 5,69x
Capitalization 2 363 M
More Financials
Company
Nevro Corp. engages in the provision of medical devices.It develops and commercializes senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain.The company was founded by Konstantinos Alataris in March 2006 and is headquartered in Redwood... 
More about the company
Surperformance© ratings of Nevro Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on NEVRO CORP
01/08 NEVRO : Receives FDA Approval for Senza II™ Spinal Cord Stimulation System..
01/08 NEVRO CORP : Results of Operations and Financial Condition, Financial Statements..
01/08 NEVRO : Announces Preliminary Unaudited Fourth Quarter and Fiscal Year 2017 Reve..
2017 NEVRO : to Present at the 36th Annual J.P. Morgan Healthcare Conference
2017 NEVRO CORP : Free Research Report as Nevro’s Revenue Grew 35%
2017 NEVRO : SmartTRAK's Top 10 Medical Device Blog Posts in 2017
2017 NEVRO : Neurostimulation implant Supplies
2017 NEVRO : Reports Third Quarter 2017 Financial Results
2017 NEVRO : Management's Discussion and Analysis of Financial Condition and Results ..
2017 NEVRO : reports 3Q loss
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
01/12 China cracks down on foreign companies calling Taiwan, other regions countrie..
01/12 China cracks down on foreign companies calling Taiwan, other regions countrie..
01/12 Delta, Zara and Medtronic Join Marriott in Beijing's Doghouse After Location ..
01/08 MALLINCKRODT : to Sell Two Hemostasis Products to Baxter
01/07 BAXTER INTERNATIONAL : Hospitals Wrestle With Shortage of IV Bags, Linked to Hur..
More sector news : Medical Equipment, Supplies & Distribution - NEC
Latest Tweets
01/17This Morning's Technical Outlook on Medical Equipment Stocks -- Nxstage Medic.. 
01/16$NVRO - Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Nevro #.. 
01/12Nevro to Highlight Body of Clinical Evidence Supporting Expanded Use and Pote.. 
01/11Nevro $NVRO Receiving Somewhat Favorable Media Coverage, Report Finds  
01/09Nevro Corp. (NVRO) Climbed After FDA Approval: Nevro Corp. (NVRO) announced M.. 
More tweets
Qtime:29
News from SeekingAlpha
01/17 NEVRO : Rebound Likely In 2018
01/09 Nevro (NVRO) Presents At 36th Annual J.P. Morgan Healthcare Conference - Slid..
01/08 Midday Gainers / Losers
01/08 FDA OKs Nevro's Senza II SCS; shares ahead 16%
01/08 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
Chart NEVRO CORP
Duration : Period :
Nevro Corp Technical Analysis Chart | NVRO | US64157F1030 | 4-Traders
Technical analysis trends NEVRO CORP
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Average target price 102 $
Spread / Average Target 27%
EPS Revisions
Managers
NameTitle
Rami Elghandour President, Chief Executive Officer & Director
Michael F. DeMane Chairman
Patrick Schmitz Vice President-Operations
Andrew H. Galligan CFO & Principal Accounting Officer
David Caraway Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
NEVRO CORP15.51%2 363
MEDTRONIC PLC5.82%115 480
BAXTER INTERNATIONAL5.72%36 869
ZIMMER BIOMET HOLDINGS1.19%24 637
ALIGN TECHNOLOGY16.31%21 157
HOYA CORPORATION-2.00%19 581